Purna Pharmaceuticals
ActivePurna Pharmaceuticals has been active since 1986 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €19.39M and a net result of €2.82M. Equity is growing by ~14.6% per year across the filed fiscal years. Its solvency ranks better than 65% of 64 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
80
/ 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability80▲+1
Solvency82▲+11
Growth68▼-3
Track record100
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €1.55M at 30 days acceptable
Liquidity tight (current ratio 1.31 against 0.98 in 2024; short-term debt: 25% and cash: 0.5% of total assets), and 43.5% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
56.5%
Return on assets
8.2%
Age of the figures
9 mo
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 21
Relative position
BE, all sectors
reference
Sector 21
higher
← fewer bankruptcies
more bankruptcies →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 05-06-2026, 56 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
56 d early
2024
70 d early
2023
54 d early
2022
73 d early
2021
48 d early
2020
33 d early
2019
25 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
23-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, full schema
Turnover
€43.23M▼ 5.9%
2024 · €45.95M
2018: €30.51M
2019: €36.90M
2020: €43.08M
2021: €33.80M
2022: €37.43M
2023: €37.74M
2024: €45.95M
2018 → 2025
EBIT margin
7.4%▼ 0.2pp
2024 · 7.6%
2018: -3.1%
2019: 0.5%
2020: 5.6%
2021: -0.6%
2022: -1.0%
2023: -7.4%
2024: 7.6%
2018 → 2025
Net result
€2.82M▲ 4.2%
2024 · €2.71M
2018: €-1.46M
2019: €33k
2020: €1.87M
2021: €-576k
2022: €-745k
2023: €-3.38M
2024: €2.71M
2018 → 2025
Working capital
€2.66M
2024 · €-250k
2018: €2.98M
2019: €2.20M
2020: €3.71M
2021: €2.38M
2022: €1.58M
2023: €-2.43M
2024: €-250k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Turnover€33.80M-€37.43M▲ 10.7%€37.74M▲ 0.9%€45.95M▲ 21.7%€43.23M▼ 5.9%
Equity€9.03M-€8.18M▼ 9.4%€11.15M▲ 36.3%€16.70M▲ 49.8%€19.39M▲ 16.1%
Operating result€-199k-€-371k▼ 86.1%€-2.79M▼ 652%€3.51M€3.22M▼ 8.4%
Net result€-576k-€-745k▼ 29.4%€-3.38M▼ 353%€2.71M€2.82M▲ 4.2%
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 8% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €34.31M
Fixed assets
€23.09M▼ 8.6%
Current assets
€11.23M▲ 2.9%
Equity and liabilities €34.31M
Equity
€19.39M▲ 16.1%
Provisions
€29k=
Debt
€14.90M▼ 23.3%
The debt ratio falls from 53.7% to 43.4%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€6.62M▼
2024 · €6.90M
Cash flow
€6.22M▲
2024 · €6.10M
Solvency
56.5%▲
2024 · 46.2%
Current ratio
1.31▲
2024 · 0.98
Quick ratio
0.73▲
2024 · 0.47
Debt / equity
0.77▼
2024 · 1.16
ROE
14.5%▼
2024 · 16.2%
ROA
8.2%▲
2024 · 7.5%
Interest coverage
13.18▲
2024 · 9.04
Debt
€14.90M▼
2024 · €19.42M
Debt ≤ 1 year
€8.57M▼
2024 · €11.15M
Debt > 1 year
€4.55M▼
2024 · €6.68M
Income taxes
€-19k▼
2024 · €116k
Staff costs
€12.61M▲
2024 · €11.81M
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€36.15M€34.31M▼
Fixed assets21/28€25.25M€23.09M▼
Intangible fixed assets21€1.77M€1.68M▼
Tangible fixed assets22/27€23.47M€21.40M▼
Land and buildings22€14.40M€13.93M▼
Plant, machinery and equipment23€5.65M€5.08M▼
Furniture and vehicles24€90k€58k▼
Leasing and similar rights25€3.32M€2.33M▼
Financial fixed assets28€4k€4k=
Other financial fixed assets284/8€4k€4k=
Amounts receivable and cash guarantees285/8€4k€4k=
Current assets29/58€10.90M€11.23M▲
Stocks and contracts in progress3€5.62M€4.97M▼
Stocks30/36€5.62M€4.97M▼
Raw materials and consumables30/31€4.76M€4.19M▼
Finished goods33€864k€774k▼
Amounts receivable within one year40/41€5.04M€5.95M▲
Trade receivables40€4.58M€5.65M▲
Other amounts receivable41€463k€296k▼
Cash at bank and in hand54/58€50k€173k▲
Deferred charges and accrued income490/1€185k€140k▼
Equity and liabilities
Total equity and liabilities10/49€36.15M€34.31M▼
Equity10/15€16.70M€19.39M▲
Contributions10/11€2.94M€2.94M=
Capital10€610k€610k=
Issued capital100€610k€610k=
Outside capital11€2.33M€2.33M=
Share premium1100/10€2.33M€2.33M=
Revaluation surpluses12€9.40M€9.40M=
Reserves13€65k€65k=
Non-distributable reserves130/1€61k€61k=
Legal reserve130€61k€61k=
Distributable reserves133€4k€4k=
Profit (loss) carried forward14€3.89M€6.71M▲
Investment grants15€403k€274k▼
Provisions and deferred taxes16€29k€29k=
Deferred taxes168€29k€29k=
Amounts payable17/49€19.42M€14.90M▼
Amounts payable after more than one year17€6.68M€4.55M▼
Financial debts170/4€6.68M€4.55M▼
Leasing and similar obligations172€1.85M€794k▼
Credit institutions173€4.84M€3.76M▼
Amounts payable within one year42/48€11.15M€8.57M▼
Current portion of amounts payable after more than one year42€2.23M€2.12M▼
Financial debts43€1.92M€1.15M▼
Credit institutions430/8€1.92M€1.15M▼
Trade debts44€5.71M€4.00M▼
Suppliers440/4€5.71M€4.00M▼
Taxes, remuneration and social security45€1.29M€1.30M▲
Taxes450/3€114k€4k▼
Remuneration and social security454/9€1.18M€1.29M▲
Accrued charges and deferred income492/3€1.59M€1.77M▲
Income statement
Code20242025
Operating income70/76A€46.58M€44.49M▼
Turnover70€45.95M€43.23M▼
Change in stocks of work in progress, finished goods and contracts in progress71€-448k€-89k▲
Other operating income74€1.08M€1.35M▲
Operating charges60/66A€43.07M€41.27M▼
Goods for resale, raw materials and consumables60€18.90M€15.95M▼
Purchases600/8€18.79M€15.29M▼
Change in stocks: decrease (increase)609€109k€664k▲
Services and other goods61€8.54M€9.01M▲
Remuneration, social security and pensions62€11.81M€12.61M▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€3.39M€3.40M▲
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€-10k€-94k▼
Other operating charges640/8€443k€393k▼
Operating profit (loss)9901€3.51M€3.22M▼
Financial income75/76B€115k€111k▼
Recurring financial income75€115k€111k▼
Other financial income752/9€115k€111k▼
Financial charges65/66B€802k€526k▼
Recurring financial charges65€802k€526k▼
Debt charges650€764k€502k▼
Other financial charges652/9€39k€24k▼
Profit (loss) for the period before taxes9903€2.82M€2.80M▼
Income taxes67/77€116k€-19k▼
Taxes670/3€116k-
Tax adjustments and reversals of tax provisions77-€19k
Profit (loss) for the period9904€2.71M€2.82M▲
Profit (loss) for the period to be appropriated9905€2.71M€2.82M▲
Appropriation of the result
Profit (loss) to be appropriated9906€3.89M€6.71M▲
Profit (loss) brought forward from the previous period14P€1.18M€3.89M▲
Social balance
Average headcount (FTE)9087181.2182.6▲
The notes to these accounts (61 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
05-06
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
02-02
State Gazette act
Capital & shares · Purpose · Statutes amendment · Resignations & appointmentsGeneral meeting · Purpose change · Corporate purpose19 facts ▸
State Gazette act
Capital & shares · Purpose · Statutes amendment · Resignations & appointments
General meeting · Purpose change · Corporate purpose19 facts ▸
- General meeting, 2026-01-20
- Purpose change, Wijziging van het voorwerp door vervanging van artikel 3
- Corporate purpose, Het ontwikkelen, formuleren, onderzoeken, valideren, produceren, vervaardigen, assembleren, verpakken, etiketteren, distribueren en verhandelen van farmaceutisc…
- Capital, €610.047,07
- Statutes amendment
- Statutes amendment
- Director resignation, Creafund Asset Management NV (bestuurder)
- Director resignation, Bart M.J. Peeters BV (bestuurder)
- Director resignation, Lea Smets (bestuurder)
- Director resignation, Raymond Van Gucht (bestuurder)
- Director discharge, Creafund Asset Management NV
- Director discharge, Bart M.J. Peeters BV
- +7 further facts in this act
2025
31-12
Financial
Highest result since 2018net €2.82M ▲4.2%
Net result €2.82M, the highest in the series.
17-06
State Gazette act
Resignations & appointmentsGeneral meeting · Director discharge · Auditor reappointment5 facts ▸
State Gazette act
Resignations & appointments
General meeting · Director discharge · Auditor reappointment5 facts ▸
- General meeting, 2025-05-06
- Director discharge, Purna Pharmaceuticals
- Auditor reappointment, Nijs Karel (bedrijfsrevisor-commissaris)
- Director appointment, Van Gucht Raymond (bestuurder)
- Director appointment, Van Gucht Raymond (voorzitter Raad van Bestuur)
22-05
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
23-04
State Gazette act
Resignations & appointmentsBoard meeting · Permanent representative · Power of attorney3 facts ▸
State Gazette act
Resignations & appointments
Board meeting · Permanent representative · Power of attorney3 facts ▸
- Board meeting, 2025-02-27
- Permanent representative, Ruth De Wulf
- Power of attorney, Pieter-Jan Van Houdenhove
2024
31-12
Financial
Back to profitnet €2.71M
Net result €2.71M after 3 loss-making years.
07-06
NBB filing
Annual accounts filed
fiscal year 2023 · full schema
13-03
State Gazette act
Statutes amendmentGeneral meeting · Statutes amendment · Capital7 facts ▸
State Gazette act
Statutes amendment
General meeting · Statutes amendment · Capital7 facts ▸
- General meeting, 2023-12-19
- Statutes amendment
- Statutes amendment
- Statutes amendment
- Statutes amendment
- Capital, €610.047,07
- Corporate purpose, De fabricatie van vaselines, alle soorten zalven, artsenijproducten; de verwerking en het raffineren van minerale, plantaardige en dierlijke oliën en vetten, de…
2023
31-12
Financial
Weakest financial yearnet €-3.38M
Net result drops to €-3.38M, the lowest in the series; recovery starts the following year.
31-12
Financial
Equity above €10MEq €11.15M ▲36.3%
Equity rises from €8.18M to €11.15M.
19-05
NBB filing
Annual accounts filed
fiscal year 2022 · full schema
2022
29-06
State Gazette act
Resignations & appointmentsGeneral meeting · Director discharge · Auditor discharge4 facts ▸
State Gazette act
Resignations & appointments
General meeting · Director discharge · Auditor discharge4 facts ▸
- General meeting, 2022-05-04
- Director discharge, Van Gucht Raymond
- Auditor discharge, 2022-05-04
- Auditor reappointment, Purna Pharmaceuticals
13-06
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
2021
30-08
State Gazette act
Resignations & appointmentsGeneral meeting · Director reappointment · Permanent representative17 facts ▸
State Gazette act
Resignations & appointments
General meeting · Director reappointment · Permanent representative17 facts ▸
- General meeting, 2021-05-05
- Director reappointment, Lea Smets (bestuurder)
- Director reappointment, Raymond Van Gucht (bestuurder)
- Director reappointment, Bart M.J. Peeters BVBA (bestuurder)
- Director reappointment, Creafund Asset Management NV (bestuurder)
- Permanent representative, Bart Peeters
- Permanent representative, Herman Wielfaert
- Director discharge, Lea Smets
- Director discharge, Raymond Van Gucht
- Director discharge, Bart M.J. Peeters BVBA
- Director discharge, Creafund Asset Management NV
- Auditor discharge, BVBA Karel Nijs
- +5 further facts in this act
28-06
NBB filing
Annual accounts filed
fiscal year 2020 · full schema
2020
06-07
NBB filing
Annual accounts filed
fiscal year 2019 · full schema
2019
31-12
Financial
Back to profitnet €33k
Net result €33k after one loss-making year.
13-12
State Gazette act
Resignations & appointmentsAuditor reappointment · Permanent representative2 facts ▸
State Gazette act
Resignations & appointments
Auditor reappointment · Permanent representative2 facts ▸
- Auditor reappointment, Nijs Roeckens Bedrijfsrevisoren BVBA
- Permanent representative, Karel Nijs
12-06
NBB filing
Annual accounts filed
fiscal year 2018 · full schema
22-05
State Gazette act
Resignations & appointmentsBoard meeting · Permanent representative2 facts ▸
State Gazette act
Resignations & appointments
Board meeting · Permanent representative2 facts ▸
- Board meeting
- Permanent representative, Herman Wielfaert
2018
08-11
State Gazette act
Resignations & appointmentsDirector resignation · Director appointment · Permanent representative4 facts ▸
State Gazette act
Resignations & appointments
Director resignation · Director appointment · Permanent representative4 facts ▸
- Director resignation, True North Asset Management NV (bestuurder)
- Director appointment, Creafund Asset Management NV (bestuurder)
- Permanent representative, Herman Wielfaert
- Power of attorney, H&H Capital Management BVBA
20-07
State Gazette act
Resignations & appointmentsGeneral meeting · Director resignation · Permanent representative5 facts ▸
State Gazette act
Resignations & appointments
General meeting · Director resignation · Permanent representative5 facts ▸
- General meeting, 2018-06-25
- Director resignation, IFC Services BVBA (bestuurder)
- Permanent representative, Johan Heirbrandt
- Director appointment, True North Asset Management (bestuurder)
- Permanent representative, Bernard Hendrikx
12-07
NBB filing
Annual accounts filed
fiscal year 2017 · full schema
27-02
State Gazette act
Resignations & appointmentsAuditor reappointment · Permanent representative2 facts ▸
State Gazette act
Resignations & appointments
Auditor reappointment · Permanent representative2 facts ▸
- Auditor reappointment, Nijs Roeckens Bedrijfsrevisoren BVBA
- Permanent representative, Karel Nijs
2017
21-06
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
2016
24-06
State Gazette act
Resignations & appointmentsGeneral meeting · Auditor reappointment2 facts ▸
State Gazette act
Resignations & appointments
General meeting · Auditor reappointment2 facts ▸
- General meeting, 2016-05-03
- Auditor reappointment, Karel Nijs (commissaris - revisor)
2015
10-07
State Gazette act
Resignations & appointmentsGeneral meeting · Director reappointment · Permanent representative10 facts ▸
State Gazette act
Resignations & appointments
General meeting · Director reappointment · Permanent representative10 facts ▸
- General meeting, 2015-05-05
- Director reappointment, Smets Lea (bestuurder)
- Director reappointment, Van Gucht Raymond (bestuurder)
- Director reappointment, Bart M.J. Peeters BVBA (bestuurder)
- Director reappointment, IFC Services BVBA (bestuurder)
- Permanent representative, Peeters Bart
- Permanent representative, Heirbrandt-Van Rijsseghem Johan
- Board meeting, 2015-05-05
- Director appointment, Van Gucht Raymond (gedelegeerd bestuurder)
- Director appointment, Van Gucht Raymond (voorzitter van de Raad van Bestuur)
16-06
State Gazette act
Resignations & appointmentsGeneral meeting · Director reappointment · Permanent representative10 facts ▸
State Gazette act
Resignations & appointments
General meeting · Director reappointment · Permanent representative10 facts ▸
- General meeting, 05/05/2015
- Director reappointment, Smets Lea (bestuurder)
- Director reappointment, Van Gucht Raymond (bestuurder)
- Director reappointment, Bart M.J. Peeters BVBA (bestuurder)
- Director reappointment, Net Consulting BVBA (bestuurder)
- Permanent representative, Peeters Bart
- Permanent representative, Heirbrandt-Van Rijsseghem Johan
- Board meeting, 05/05/2015
- Director appointment, Van Gucht Raymond (gedelegeerd bestuurder)
- Director appointment, Van Gucht Raymond (voorzitter van de Raad van Bestuur)
2013
01-08
State Gazette act
Resignations & appointmentsGeneral meeting · Auditor appointment · Permanent representative3 facts ▸
State Gazette act
Resignations & appointments
General meeting · Auditor appointment · Permanent representative3 facts ▸
- General meeting, 2013-05-06
- Auditor appointment, Burg. BVBA Nijs en Partners Bedrijfsrevisoren (commissaris)
- Permanent representative, Karel Nijs
25-03
State Gazette act
Resignations & appointmentsGeneral meeting · Director resignation · Director appointment5 facts ▸
State Gazette act
Resignations & appointments
General meeting · Director resignation · Director appointment5 facts ▸
- General meeting, 26/06/2012
- Director resignation, Net Consulting BVBA (bestuurder)
- Director appointment, IFC Services BVBA (bestuurder)
- Permanent representative, Johan Heirbrandt-Van Rysseghem
- Permanent representative, Johan Heirbrandt-Van Rysseghem
2011
22-07
State Gazette act
Resignations & appointmentsGeneral meeting · Director reappointment · Permanent representative11 facts ▸
State Gazette act
Resignations & appointments
General meeting · Director reappointment · Permanent representative11 facts ▸
- General meeting, 2009-05-06
- Director reappointment, Smets Lea (bestuurder)
- Director reappointment, Van Gucht Raymond (bestuurder)
- Director reappointment, Bart M.J. Peeters BVBA (bestuurder)
- Permanent representative, Peeters Bart
- Director reappointment, Net Consulting BVBA (bestuurder)
- Permanent representative, Heirbrandt-Van Rijsseghem Johan
- Board meeting, 2009-05-05
- Director appointment, Van Gucht Raymond (gedelegeerd bestuurder)
- General meeting, 2010-05-06
- Auditor reappointment, Borré Werner (commissaris-revisor)
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
11 directors, no change since 2026
Hidde Van Kerckhoven
CurrentDirector · since 20-01-2026
Peeters Bart
CurrentManaging director · since 05-05-2021
Bart M.J. Peeters
CurrentDirector · since 06-05-2009 · Private limited company · perm. rep.: Peeters Bart
CREAFUND
CurrentDirector · Public limited company · perm. rep.: Herman Wielfaert
True North Asset Management
Not recently confirmedDirector · since 25-06-2018 · Private limited company · perm. rep.: Bernard Hendrikx
20-01-2026
Hidde Van Kerckhoven: Appointed as Director
20-01-2026
Peeters Bart: Resigned as Managing director
20-01-2026
Bart M.J. Peeters BV: Resigned as Director
20-01-2026
NV CREAFUND ASSET MANAGEMENT: Resigned as Director
20-01-2026
Smets Lea: Resigned as Director
20-01-2026
Van Gucht Raymond: Resigned as Director
06-05-2025
Van Gucht Raymond: Appointed as Voorzitter raad van bestuur
06-05-2025
Van Gucht Raymond: Appointed as Director
05-05-2021
Peeters Bart: Appointed as Managing director
05-05-2021
Van Gucht Raymond: Appointed as Chair
20-09-2018
NV CREAFUND ASSET MANAGEMENT: Appointed as Director
20-09-2018
TRUE NORTH ASSET MANAGEMENT NV: Resigned as Director
25-06-2018
True North Asset Management: Appointed as Director
25-06-2018
IFC Services: Resigned as Director
05-05-2015
Bart M.J. Peeters: Mandate renewed as Director
05-05-2015
Smets Lea: Mandate renewed as Director
05-05-2015
Van Gucht Raymond: Appointed as Voorzitter van de raad van bestuur
05-05-2015
Van Gucht Raymond: Mandate renewed as Director
05-05-2015
Van Gucht Raymond: Appointed as Managing director
05-05-2015
IFC Services: Mandate renewed as Director
01-07-2012
IFC Services: Appointed as Director
06-05-2009
Bart M.J. Peeters: Mandate renewed as Director
06-05-2009
Smets Lea: Mandate renewed as Director
06-05-2009
Van Gucht Raymond: Mandate renewed as Director
+ 1 not shown in this overview
Location & real-estate footprint
Registered office, Puurs-Sint-Amands · 1 establishment unit since 1986
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Rijksweg 172870 Puurs-Sint-AmandsGround area
1.4 ha
Building footprint
7,378 m²
Volume, LiDAR
55,267 m³
Parcel 12030D0103/00F003, Flanders · tallest building 13.6 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
PURNA
since 19862.033.640.632
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 12030D0103/00F003 | Flanders | 1.4 ha | 1 · 7,378 m² | 13.6 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Statutory auditor
5 auditors| BVBA Karel NijsCurrent Auditor · represented by Karel Nijs | 05-05-2021 → present |
Show 4 earlier auditors
| Borré Werner Commissaris revisor succeeded by Burg. BVBA Nijs en Partners Bedrijfsrevisoren in 2013 | 06-05-2009 → 06-05-2013 |
| Burg. BVBA Nijs en Partners Bedrijfsrevisoren Statutory auditor · represented by Karel Nijs succeeded by Karel NIJS in 2016 | 06-05-2013 → 03-05-2016 |
| Karel NIJS Bedrijfsrevisor commissaris succeeded by Nijs Roeckens bedrijfsrevisoren BVBA in 2018 | 03-05-2016 → 15-02-2018 |
| Nijs Roeckens bedrijfsrevisoren BVBA Auditor · represented by Karel Nijs succeeded by BVBA Karel Nijs in 2021 | 15-02-2018 → 05-05-2021 |
Structure & network
Connections & network
15 connected companiesLinked via shared directors
viaPEETERS Bart · Permanent representative
→
viaPEETERS Bart · Permanent representative
→
viaPEETERS Bart · Director
former→
viaPEETERS Bart · Director
former→
Show 6 more companies with a shared director
viaPEETERS Bart · Director
former→
viaPEETERS Bart · Director
former→
viaPEETERS Bart · Director
former→
viaPEETERS Bart · Lid en bestuurder, ondervoorzitter glasgroenten
former→
viaPEETERS Bart · Director
former→
viaPEETERS Bart · Director
former→
Network connections
Shared corporate director
→
Shared corporate director
→
Shared corporate director
→
Shared corporate director
→
Show 1 more network connections
Shared corporate director
→
Ownership & control
4 partiesControl over this companysits on this company's board4
5 subsidiaries · 1 location
2 subsidiaries · 1 location
1 subsidiary · 1 location
1 subsidiary · 1 location
controls
Purna PharmaceuticalsBE 0428.742.176
Public money · subsidies and aid
Flemish government
2022 to 2025 · 14 entries · 550,453 EUR awarded · 463,762 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2025 | 5 | 19,408 EUR | 20,398 EUR |
| 2024 | 4 | 18,655 EUR | 17,665 EUR |
| 2023 | 4 | 85,699 EUR | 255,699 EUR |
| 2022 | 1 | 426,691 EUR | 170,000 EUR |
Schemes
Onderzoeksproject
Subsidies voor internationaal ondernemen
Individueel Maatwerk
Vlaams opleidingsverlof (VOV)
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
Recognitions · licences · registrations
Legal Entity Identifier
549300CWVCPOJCECRT27
Similar companies · same sector, comparable size
ORFIT INDUSTRIES
BE 0423.393.221
Wijnegem · Eq €18.38M
Opella Healthcare Belgium NV/SA
BE 0753.785.218
Machelen (Brab.) · Eq €20.67M
KANEKA EUROGENTEC
BE 0427.348.346
Seraing · Eq €20.76M
Cryotherapeutics
BE 0713.882.584
Ans · Eq €21.09M
S.M.B. TECHNOLOGY
BE 0431.842.812
Marche-en-Famenne · Eq €17.05M
Of 97 companies in sector 21209 we hold annual accounts for 74. 28 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPublic limited company
Founded04-04-1986
Fiscal year end31-12
Activities, NACEBEL
21201Manufacture of basic pharmaceutical products and pharmaceutical preparations
21209Manufacture of basic pharmaceutical products and pharmaceutical preparations
24422
46460Wholesale of pharmaceutical and medical goods
Sources
Crossroads Bank for EnterprisesNational Bank · 40 filingsAddress and cadastre registers
Data from official sources, last processed on 23-09-2026. Scores and ratios are computed by Checked and are not a credit decision.